Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.

Schnabel RB, Larson MG, Yamamoto JF, Sullivan LM, Pencina MJ, Meigs JB, Tofler GH, Selhub J, Jacques PF, Wolf PA, Magnani JW, Ellinor PT, Wang TJ, Levy D, Vasan RS, Benjamin EJ.

Circulation. 2010 Jan 19;121(2):200-7. doi: 10.1161/CIRCULATIONAHA.109.882241. Epub 2010 Jan 4.

2.

C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.

Wilson PW, Pencina M, Jacques P, Selhub J, D'Agostino R Sr, O'Donnell CJ.

Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):92-7. doi: 10.1161/CIRCOUTCOMES.108.831198. Epub 2008 Nov 9.

3.

Assessment of claims of improved prediction beyond the Framingham risk score.

Tzoulaki I, Liberopoulos G, Ioannidis JP.

JAMA. 2009 Dec 2;302(21):2345-52. doi: 10.1001/jama.2009.1757. Review.

PMID:
19952321
4.

Predicting the 30-year risk of cardiovascular disease: the framingham heart study.

Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS.

Circulation. 2009 Jun 23;119(24):3078-84. doi: 10.1161/CIRCULATIONAHA.108.816694. Epub 2009 Jun 8.

5.

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.

Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC Jr, Wilson PW; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council.

Circulation. 2009 May 5;119(17):2408-16. doi: 10.1161/CIRCULATIONAHA.109.192278. Epub 2009 Apr 13. Erratum in: Circulation. 2009 Jun 30;119(25):e606. Hong, Yuling [added].

6.

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.

Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RB Sr, Newton-Cheh C, Yamamoto JF, Magnani JW, Tadros TM, Kannel WB, Wang TJ, Ellinor PT, Wolf PA, Vasan RS, Benjamin EJ.

Lancet. 2009 Feb 28;373(9665):739-45. doi: 10.1016/S0140-6736(09)60443-8.

7.

Genotype score in addition to common risk factors for prediction of type 2 diabetes.

Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, Manning AK, Florez JC, Wilson PW, D'Agostino RB Sr, Cupples LA.

N Engl J Med. 2008 Nov 20;359(21):2208-19. doi: 10.1056/NEJMoa0804742. Erratum in: N Engl J Med. 2009 Feb 5;360(6):648.

8.

Assessing the value of risk predictions by using risk stratification tables.

Janes H, Pepe MS, Gu W.

Ann Intern Med. 2008 Nov 18;149(10):751-60.

9.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.

N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.

10.

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.

Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR.

Circulation. 2008 Nov 25;118(22):2243-51, 4p following 2251. doi: 10.1161/CIRCULATIONAHA.108.814251. Epub 2008 Nov 9.

11.

General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB.

Circulation. 2008 Feb 12;117(6):743-53. doi: 10.1161/CIRCULATIONAHA.107.699579. Epub 2008 Jan 22.

12.

A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study.

Parikh NI, Pencina MJ, Wang TJ, Benjamin EJ, Lanier KJ, Levy D, D'Agostino RB Sr, Kannel WB, Vasan RS.

Ann Intern Med. 2008 Jan 15;148(2):102-10.

PMID:
18195335
13.

Integrating the predictiveness of a marker with its performance as a classifier.

Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, Zheng Y.

Am J Epidemiol. 2008 Feb 1;167(3):362-8. Epub 2007 Nov 2.

14.

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS.

Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12.

PMID:
17569110
15.
16.

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.

Ridker PM, Buring JE, Rifai N, Cook NR.

JAMA. 2007 Feb 14;297(6):611-9. Erratum in: JAMA. 2007 Apr 4;297(13):1433.

PMID:
17299196
17.

Multiple biomarkers for the prediction of first major cardiovascular events and death.

Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS.

N Engl J Med. 2006 Dec 21;355(25):2631-9.

18.

Decision curve analysis: a novel method for evaluating prediction models.

Vickers AJ, Elkin EB.

Med Decis Making. 2006 Nov-Dec;26(6):565-74.

19.

Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.

Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):127-33. Epub 2006 Nov 9.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk